GSK, Sanofi pledge 200M doses of potential COVID-19 vaccine to global alliance
Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around the world equal access to coronavirus vaccines.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed